7 US Cases of Malaria Contracted Locally for First Time in 20 Years
Six confirmed cases of malaria in Florida and 1 in Texas have not been linked to international travel.
FDA Committee Recommends COVID-19 Vaccines Should Be Monovalent, Contain the XBB Strain
The FDA committee, known as VRBPAC, in charge of evaluating vaccines and related biological products recently voted unanimously that the upcoming 2023-2024 COVID-19 vaccines should be updated with a monovalent XBB strain.
FDA Advisory Committee AMDAC Recommends Nirsevimab to Protect Infants Against RSV
Although older adults have 2 vaccines, this would be the first vaccine or antiviral option for infants.
FDA Approves Pfizer's Abrysvo Vaccine for Older Adults
The FDA's decision to approve Abrysvo was based on data from a Phase 3 clinical trial, RENOIR, demonstrating the RSV vaccine's efficacy, immunogenicity, and safety in adults 60 and older.
FDA and CDC Update COVID-19 Vaccine Recommendations
The CDC updated and simplified its vaccine recommendations on April 19, 2023, and the Moderna and Pfizer-BioNTech mRNA bivalent COVID-19 vaccines should be used for all vaccinations in the US.
Preventing Hepatitis B: We Have Vaccines, But Not Implementation
Hepatitis B prevention needs more real-world studies, according to an expert who gave a presentation at CROI.
COVID-19 Variant and Time Affects Reinfection, According to Recent Study
COVID-19 reinfection chances vary to variant and time since the previous infection, according to a new study.
Omicron XBB.1.5: Yet Another COVID-19 Variant to Know
The CDC genomic surveillance found that the XBB.1.5 variant has increased from causing 1% to over 40% in only a month.
GSK RSV Vaccine Trial Demonstrates Promising Results
The respiratory syncytial virus demonstrates effectiveness analyzing severity, age group, and comorbidity in the phase 3 vaccine trial.
Déjà vu? Langya Virus, New Novel Virus, Identified in China
Identified in at least 35 people in eastern China, a new type of henipavirus, Langya virus, is suspected to have infected shrews before jumping to humans.
Pfizer-BioNTech Booster Dose Approved for Children 5 and Older
Children 5 to 11 years old now can receive a booster shot of the Pfizer-BioNTech vaccine.
Pfizer-BioNTech Delay FDA Request for COVID-19 Vaccine for Kids Under 5
The postponement will allow for additional time to review new data regarding the emergency use authorization request.
Many Older Adults Face New Clinical Conditions After COVID-19 Infection
Investigators found that 32% of older adults diagnosed with COVID-19 sought medical attention in the post-acute period.
Monoclonal Antibody Treatments Called Ineffective Against Omicron
In making the ruling, the FDA stated that it wants to spare patients the risk of side effects such as injection site soreness or allergic reactions for treatments unlikely to work.
Long COVID Symptoms Last for a Year for Some Patients
This frequency of symptoms 1 year after recovering from severe COVID-19 disease is concerning, as much is still unknown about “long COVID.”
Fourth mRNA COVID-19 Not as Effective Against Omicron, says Study
Despite the preliminary evidence that a fourth dose will not offer sufficient protection against Omicron, Israel will continue to offer it to vulnerable populations, predicting that the variant’s contagions will wane.
COVID-19 Vaccine Does Not in Any Way Complicate Birth, says CDC
Data collected from over 46,000 pregnant women show that COVID-19 vaccination does not cause an increased risk of preterm birth or small-for-gestational-age at birth.
Children From 12 to 15 Can Get COVID-19 Boosters, Says FDA
If CDC Director Rochelle Walensky, MD, endorses the FDA’s decision, the recommendation can go into effect this week.
Take J&J COVID-19 Vaccine As Last Resort, CDC Recommends
Any COVID-19 vaccine is better than none. But the CDC recommends that people get the Janssen vaccine only if they can’t get the Pfizer/BioNTech or Moderna vaccines.
Immune Changes in Mothers, Infants Linked to COVID-19 Infection
Perhaps another reason why pregnant women should get the COVID-19 vaccine? Investigators found COVID-19 infection altered the mothers’ immunity at delivery, and gestational COVID-19 exposure alters the immunity of the newborns.
How Delta Variant Harmed Children in Arkansas
Results unveiled at IDWeek 2021 disprove any misconceptions about pediatric COVID-19 cases lacking severity.
2 Clarke Drive Cranbury, NJ 08512